Evidence map›Paper›PMID 40463974›Full record

ArticleFrontiers in medicine2025

Second-harmonic generation microscopy of murine scleral remodeling by collagenase and reparative collagen mimetic peptides.

Daniel E Savage, Aldo Tecse, Jiaxi Zhou, James A Germann, Mark R Buckley, Robert O Baratta, Brian J Del Buono, Eric Schlumpf, Michael Telias, Susana Marcos

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daniel E Savage *John A. Moran Eye Center, University of Utah, Salt Lake City, UT, United States.
Aldo Tecse *Department of Biomedical Engineering, University of Rochester, Rochester, NY, United States.
Jiaxi ZhouCenter for Visual Science, University of Rochester, Rochester, NY, United States.
James A GermannCenter for Visual Science, University of Rochester, Rochester, NY, United States.
Mark R BuckleyDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, United States.
Robert O BarattaThe Institute of Optics, University of Rochester, Rochester, NY, United States.
Brian J Del BuonoThe Institute of Optics, University of Rochester, Rochester, NY, United States.
Eric SchlumpfThe Institute of Optics, University of Rochester, Rochester, NY, United States.
Michael TeliasFlaum Eye Institute, University of Rochester, Rochester, NY, United States.
Susana MarcosCenter for Visual Science, University of Rochester, Rochester, NY, United States.

Funding

VISUAL SCIENCE RESEARCH CTR SUPPORTP30EY001319 · NEI · UNIVERSITY OF ROCHESTER · PI MICHELE RUCCI · 1985 to 2026
$17.5M
NEI NIH HHS P30 EY001319
6 · The paper itself

Abstract

Introduction: Myopia, resulting from an excessive axial elongation of the eye, is increasing worldwide at alarming rates. This investigation is a pilot study to determine if a novel collagen mimetic peptide (CMP) has a reparative function for scleral collagen organization after collagenase digestion, a cause for scleral thinning and increased creep rates, as this may have application in the pharmacologic treatment of myopia. Methods: Fresh, Results: SHG microscopy of the untreated scleral tissue showed a high degree of organization. Collagenase treatment resulted in a subjective straightening of the collagen fibers and a widening of the inter-fiber spacing with a statistically significant reduction of the OC ( Discussion: CMP treatment induced scleral collagen reorganization after collagenase digestion in murine models. These effects are consistent with inhibition or reversal of collagen enzymatic digestion. These results suggest that specific CMPs may have utility in the treatment of progressive myopia.

Indexed as

collagencollagen mimetic peptidesmyopiasclerasecond-harmonic generation

Identifiers

PMID40463974
PMCPMC12131915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.